Skip to main content
. 2021 Jul 7;2:100047. doi: 10.1016/j.crmicr.2021.100047

Fig. 4.

Fig 4

Different antibacterial strategies involving artificial activation of TA modules; (A) Prevention of TA complex formation; (B) Disruption of TA complexes; (C) Activation of cellular proteases degrading antitoxins; (D) Inhibition of TA transcription; (E) Overexpression of the TA system and subsequent removal of the activating drug (see text for details).